Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:e74-e83
Published online before print May 25, 2006, doi: 10.1161/01.RES.0000228714.15691.8a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
98/12/e74    most recent
01.RES.0000228714.15691.8av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgun, A.
Right arrow Articles by Gerbase-DeLima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgun, A.
Right arrow Articles by Gerbase-DeLima, M.
Related Collections
Right arrow Energy metabolism
Right arrow Gene expression
Right arrow Genomics
Right arrow Growth factors/cytokines
Right arrow Transplantation
Right arrowRelated Article
(Circulation Research. 2006;98:e74.)
© 2006 American Heart Association, Inc.


UltraRapid Communication

Molecular Profiling Improves Diagnoses of Rejection and Infection in Transplanted Organs

Andrey Morgun*, Natalia Shulzhenko*, Ainhoa Perez-Diez, Rosiane V.Z. Diniz, Gerdine F. Sanson, Dirceu R. Almeida, Polly Matzinger{ddagger}, Maria Gerbase-DeLima{ddagger}

From the Immunogenetics Division (A.M., N.S., G.F.S., M.G.-D.), Pediatrics Department; Cardiology Division (R.V.Z.D., D.R.A.), Medicine Department, Federal University of São Paulo, Brazil; and Ghost Lab (A.M., N.S., A.P.-D., P.M.); Laboratory of Cellular and Molecular Immunology; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Md.

Correspondence to Andrey Morgun, 9000 Rockville Pike, Bldg 4, Rm 111, Bethesda, MD 20892. E-mail anemorgun{at}hotmail.com

The monitoring of transplanted hearts is currently based on histological evaluation of endomyocardial biopsies, a method that is fairly insensitive and that does not always accurately discriminate between rejection and infection in the heart. Accurate diagnosis of rejection and infection is absolutely crucial, however, as the respective treatments are completely different. Using microarrays, we analyzed gene expression in 76 cardiac biopsies from 40 heart recipients undergoing rejection, no rejection, or Trypanosoma cruzi infection. We found a set of genes whose expression patterns were typical of acute rejection, and another set of genes that discriminated between rejection and T cruzi infection. These sets revealed acute rejection episodes up to 2 weeks earlier, and trypanosome infection up to 2 months earlier than did histological evaluation. When applied to raw data from other institutions, the 2 sets of predictive genes were also able to accurately pinpoint acute rejection of lung and kidney transplants, as well as bacterial infections in kidneys. In addition to their usefulness as diagnostic tools, the data suggest that there are similarities in the biology of the processes involved in rejection of different grafts and also in the tissue responses to pathogens as diverse as bacteria and protozoa.


Key Words: cardiac transplantation • acute rejection • infection • microarray • gene expression


Related Article:

The Potential for the Transcriptome to Serve as a Clinical Biomarker for Cardiovascular Diseases
Andreas S. Barth and Joshua M. Hare
Circ. Res. 2006 98: 1459-1461. [Full Text] [PDF]



This article has been cited by other articles:


Home page
CirculationHome page
B. Heidecker, E. K. Kasper, I. S. Wittstein, H. C. Champion, E. Breton, S. D. Russell, M. M. Kittleson, K. L. Baughman, and J. M. Hare
Transcriptomic Biomarkers for Individual Risk Assessment in New-Onset Heart Failure
Circulation, July 15, 2008; 118(3): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Ashrafian and H. Watkins
Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype
J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. S. Barth and J. M. Hare
The Potential for the Transcriptome to Serve as a Clinical Biomarker for Cardiovascular Diseases
Circ. Res., June 23, 2006; 98(12): 1459 - 1461.
[Full Text] [PDF]